glp-1 substance abuse Frontiers GLP-1 medications get at the

Sildenafil and other phosphodiesterase-5 inhibitors have shown promise in mitigating doxorubicin-induced cardiotoxicity

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity medicalxpress.com To view or add a comment, sign in FDA Approval Update: Foundayo (orforglipron) On April 1, 2026, the U.S

Moreover, dumping syndrome impairs the quality of life of patients so it should be considered a deleterious complication in these patients

But here's what many people miss: it's not just about eating more protein

Clinical trials have shown that participants can lose between 15% and 20% of their body weight over 72 weeks

Our write-up above is an editorial review, not a medical recommendation